ArticleThoracic cancer2022

Treatment with immune checkpoint inhibitors after EGFR-TKIs in EGFR-mutated lung cancer.

Takashi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.